The pharmaceutical industry -- The biotechnology industry -- Generics and biosimilars -- The global pharmaceutical industry -- The demand for pharmaceuticals -- The demand for pharmaceuticals in major international markets -- Pharmaceutical prices -- Economic evaluation of new drugs -- Pricing...

"This book charts the emergence of India onto the global economic stage. In the 1990s, Indian policymakers, politicians, and private sector actors were wary of the global world. By 2015 trade constituted half of India's GDP and India had become an integral part of the world order. Indian...

1. Policy process / Alan Lyles -- 2. Federal legislative process / Valerie Heitshusen -- 3. Role of federal regulations and how they are developed / Curtis W. Copeland -- 4. Access, quality, and cost / Julie A. Schmittdiel and Marsha Raebel -- 5. Why is medication use less than appropriate? /...

What does innovation mean to and in India? What are the predominant sites of activity where Indians innovate, and under what situations do they work or fail? This book addresses these all-important questions arising within diverse Indian contexts: informal economy, low-cost settings, large...

"Researchers in international development have long argued that the high costs of doing business harms prosperity in developing countries, a claim that invites the question of why governments impose these costs and why societies fail to enact reforms reducing them. This book seeks to answer the...

When the Medicare program was created in 1965, outpatient prescription drugs were left out of the benefit package, a decision that maintained consistency with standard private insurance plans of the time. Cost was one factor behind the exclusion, but a more fundamental reason related to the role...